127.67
price up icon2.30%   3.29
 
loading
Schlusskurs vom Vortag:
$124.38
Offen:
$124.02
24-Stunden-Volumen:
87,908
Relative Volume:
0.11
Marktkapitalisierung:
$7.47B
Einnahmen:
$633.51M
Nettoeinkommen (Verlust:
$-8.10M
KGV:
-411.84
EPS:
-0.31
Netto-Cashflow:
$131.26M
1W Leistung:
+3.15%
1M Leistung:
+7.76%
6M Leistung:
-11.61%
1J Leistung:
+3.17%
1-Tages-Spanne:
Value
$123.10
$127.67
1-Wochen-Bereich:
Value
$121.44
$127.40
52-Wochen-Spanne:
Value
$102.97
$182.52

Repligen Corp Stock (RGEN) Company Profile

Name
Firmenname
Repligen Corp
Name
Telefon
(781) 449-9560
Name
Adresse
41 SEYON STREET, WALTHAM, MA
Name
Mitarbeiter
1,778
Name
Twitter
@repligen
Name
Nächster Verdiensttermin
2024-11-12
Name
Neueste SEC-Einreichungen
Name
RGEN's Discussions on Twitter

Vergleichen Sie RGEN mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Medical Instruments & Supplies icon
RGEN
Repligen Corp
127.67 7.47B 633.51M -8.10M 131.26M -0.31
Medical Instruments & Supplies icon
ISRG
Intuitive Surgical Inc
538.04 189.82B 8.71B 2.48B 1.75B 6.82
Medical Instruments & Supplies icon
BDX
Becton Dickinson Co
177.87 49.98B 20.87B 1.50B 2.59B 5.24
Medical Instruments & Supplies icon
ALC
Alcon Inc
88.92 44.00B 9.93B 1.12B 1.58B 2.25
Medical Instruments & Supplies icon
RMD
Resmed Inc
256.83 37.05B 5.02B 1.31B 1.56B 8.91
Medical Instruments & Supplies icon
WST
West Pharmaceutical Services Inc
223.66 16.36B 2.90B 467.20M 306.90M 6.37

Repligen Corp Stock (RGEN) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-04-29 Hochstufung Wolfe Research Peer Perform → Outperform
2025-03-18 Eingeleitet Evercore ISI In-line
2025-02-10 Eingeleitet TD Cowen Buy
2024-12-17 Eingeleitet Canaccord Genuity Hold
2024-11-14 Eingeleitet Wolfe Research Peer Perform
2024-08-28 Eingeleitet Wells Fargo Overweight
2024-06-26 Hochstufung Deutsche Bank Hold → Buy
2024-06-18 Eingeleitet Guggenheim Neutral
2023-12-04 Herabstufung The Benchmark Company Buy → Hold
2023-07-20 Eingeleitet Wells Fargo Overweight
2023-07-05 Fortgesetzt JP Morgan Overweight
2023-03-28 Eingeleitet The Benchmark Company Buy
2022-12-14 Eingeleitet Deutsche Bank Hold
2022-12-07 Eingeleitet RBC Capital Mkts Sector Perform
2022-07-20 Eingeleitet UBS Buy
2021-10-14 Eingeleitet Exane BNP Paribas Outperform
2020-11-10 Eingeleitet KeyBanc Capital Markets Overweight
2020-08-24 Bestätigt H.C. Wainwright Buy
2020-06-30 Bestätigt H.C. Wainwright Buy
2020-05-07 Bestätigt H.C. Wainwright Buy
2020-03-23 Bestätigt H.C. Wainwright Buy
2019-11-15 Eingeleitet Stifel Buy
2019-11-01 Hochstufung First Analysis Sec Outperform → Strong Buy
2019-10-15 Eingeleitet SVB Leerink Outperform
2019-08-28 Bestätigt First Analysis Sec Outperform
2019-08-23 Fortgesetzt Stephens Overweight
2019-07-22 Hochstufung H.C. Wainwright Neutral → Buy
2018-12-17 Hochstufung CL King Neutral → Buy
2018-11-12 Herabstufung CL King Buy → Neutral
2018-09-26 Eingeleitet H.C. Wainwright Neutral
2017-12-08 Eingeleitet Citigroup Buy
2017-12-05 Eingeleitet JP Morgan Overweight
2017-11-13 Eingeleitet CL King Buy
2017-10-02 Hochstufung First Analysis Sec Equal-Weight → Overweight
2017-07-21 Eingeleitet William Blair Outperform
2017-02-13 Hochstufung Piper Jaffray Neutral → Overweight
Alle ansehen

Repligen Corp Aktie (RGEN) Neueste Nachrichten

pulisher
Jun 16, 2025

Sarepta Therapeutics, KULR Technology Group And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga

Jun 16, 2025
pulisher
Jun 16, 2025

Yousif Capital Management LLC Has $2.01 Million Position in Repligen Co. (NASDAQ:RGEN) - Defense World

Jun 16, 2025
pulisher
Jun 13, 2025

Does Repligen Corp (RGEN) Have a Strong Pricing Power? - Insider Monkey

Jun 13, 2025
pulisher
Jun 11, 2025

Repligen Co. (NASDAQ:RGEN) Receives Consensus Rating of “Moderate Buy” from Analysts - Defense World

Jun 11, 2025
pulisher
Jun 10, 2025

Parallel Advisors LLC Has $36,000 Stock Holdings in Repligen Co. (NASDAQ:RGEN) - Defense World

Jun 10, 2025
pulisher
Jun 04, 2025

Winners And Losers Of Q1: Repligen (NASDAQ:RGEN) Vs The Rest Of The Drug Development Inputs & Services Stocks - Yahoo Finance

Jun 04, 2025
pulisher
Jun 03, 2025

Repligen at William Blair Conference: Innovation Drives Growth By Investing.com - Investing.com Canada

Jun 03, 2025
pulisher
Jun 03, 2025

Repligen at William Blair Conference: Innovation Drives Growth - Investing.com

Jun 03, 2025
pulisher
Jun 03, 2025

Repligen Corp (RGEN) Stock Price Up 5% on Jun 3 - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

Drug Development Inputs & Services Stocks Q1 In Review: Repligen (NASDAQ:RGEN) Vs Peers - Yahoo Finance

Jun 03, 2025
pulisher
Jun 02, 2025

Do Options Traders Know Something About Repligen (RGEN) Stock We Don't? - Yahoo Finance

Jun 02, 2025
pulisher
May 31, 2025

Repligen Corp (RGEN) Trading Down 3.33% on May 30 - GuruFocus

May 31, 2025
pulisher
May 29, 2025

Why Is Repligen (RGEN) Down 12.2% Since Last Earnings Report? - Yahoo Finance

May 29, 2025
pulisher
May 29, 2025

Cetera Investment Advisers Has $436,000 Position in Repligen Co. (NASDAQ:RGEN) - Defense World

May 29, 2025
pulisher
May 27, 2025

Repligen Corp (RGEN) Stock Price Up 4.35% on May 27 - GuruFocus

May 27, 2025
pulisher
May 27, 2025

Repligen Announces Publication of the Company's 2024 Corporate Sustainability Report - The Manila Times

May 27, 2025
pulisher
May 27, 2025

Repligen Announces Publication of the Company’s 2024 Corporate Sustainability Report - TradingView

May 27, 2025
pulisher
May 27, 2025

Repligen’s SWOT analysis: bioprocessing leader’s stock faces growth challenges - Investing.com

May 27, 2025
pulisher
May 27, 2025

Repligen’s SWOT analysis: bioprocessing leader’s stock faces growth challenges By Investing.com - Investing.com UK

May 27, 2025
pulisher
May 22, 2025

Repligen Corporation to Present at William Blair Growth Conference - Yahoo Finance

May 22, 2025
pulisher
May 20, 2025

Repligen at RBC Capital Markets: Strategic Growth Insights - Investing.com Australia

May 20, 2025
pulisher
May 17, 2025

Insider Sell: Anthony Hunt Sells 26,447 Shares of Repligen Corp (RGEN) - GuruFocus

May 17, 2025
pulisher
May 17, 2025

Repligen Co. (NASDAQ:RGEN) Given Average Recommendation of “Moderate Buy” by Analysts - Defense World

May 17, 2025
pulisher
May 16, 2025

Mercer Global Advisors Inc. ADV Sells 1,039 Shares of Repligen Co. (NASDAQ:RGEN) - Defense World

May 16, 2025
pulisher
May 16, 2025

Contrasting Repligen (NASDAQ:RGEN) & Maze Therapeutics (NASDAQ:MAZE) - Defense World

May 16, 2025
pulisher
May 15, 2025

Pioneering innovation in bioprocessing: Repligen’s growing impact in the area and symbiotic relationship with WWETB - Business Post

May 15, 2025
pulisher
May 13, 2025

Why Repligen Corp Stock Might Make Sense If Bought Today - Stocksregister

May 13, 2025
pulisher
May 12, 2025

Repligen, Bruker, Agilent, Medpace, and Revvity Shares Skyrocket, What You Need To Know - Yahoo Finance

May 12, 2025
pulisher
May 11, 2025

Stifel Financial Corp Grows Holdings in Repligen Co. (NASDAQ:RGEN) - Defense World

May 11, 2025
pulisher
May 08, 2025

Things To Consider Before Buying Repligen Corp (NASDAQ: RGEN) - Stocksregister

May 08, 2025
pulisher
May 08, 2025

Global Hollow Fiber Filtration Market Set to Witness - openPR.com

May 08, 2025
pulisher
May 08, 2025

M&A activity dominates Q1, nearly 99% total med-tech deal value - BioWorld MedTech

May 08, 2025
pulisher
May 08, 2025

Repligen (NASDAQ:RGEN) Upgraded to “Hold” at StockNews.com - Defense World

May 08, 2025
pulisher
May 07, 2025

Investor’s Toolkit: Key Ratios for Assessing Repligen Corp (RGEN)’s Performance - DWinneX

May 07, 2025
pulisher
May 07, 2025

Repligen Corporation to Present at Upcoming May Investor Conferences - Yahoo Finance

May 07, 2025
pulisher
May 06, 2025

Repligen (NASDAQ:RGEN) Given Buy Rating at HC Wainwright - Defense World

May 06, 2025
pulisher
May 05, 2025

Repligen (RGEN) Maintains Buy Rating with $180 Price Target | RG - GuruFocus

May 05, 2025
pulisher
May 05, 2025

Repligen (RGEN) Maintains Buy Rating with $180 Price Target | RGEN Stock News - GuruFocus

May 05, 2025
pulisher
May 03, 2025

Leerink Partnrs Has Pessimistic View of Repligen Q2 Earnings - Defense World

May 03, 2025
pulisher
May 02, 2025

Repligen Corp. (RGEN) Slid On Uncertainty Related To U.S. Federal Government Spending On Healthcare - Insider Monkey

May 02, 2025
pulisher
May 01, 2025

There is no doubt that Repligen Corp (RGEN) ticks all the boxes. - Sete News

May 01, 2025
pulisher
May 01, 2025

Jim Cramer on Repligen Corporation (RGEN): ‘I’m Not Quite Ready to Stick My Neck Out on This One’ - Insider Monkey

May 01, 2025
pulisher
May 01, 2025

Wolfe Research Upgrades Repligen (NASDAQ:RGEN) to “Outperform” - Defense World

May 01, 2025
pulisher
May 01, 2025

BlackRock, Inc. Reduces Stake in Repligen Corp: An In-Depth Anal - GuruFocus

May 01, 2025
pulisher
Apr 30, 2025

Jim Cramer Listed 20 Best Performing Stocks of the Last 20 Years - Insider Monkey

Apr 30, 2025
pulisher
Apr 30, 2025

Deep Dive Into Repligen Stock: Analyst Perspectives (8 Ratings) - Benzinga

Apr 30, 2025
pulisher
Apr 30, 2025

Wolfe Research Upgrades Repligen Corp (RGEN) to an Outperform from a Peer perform - knoxdaily.com

Apr 30, 2025
pulisher
Apr 30, 2025

RGEN Q1 Earnings Call: Repligen Delivers Above-Consensus Revenue, Raises Sales Outlook Amid Tariff Uncertainty - Yahoo Finance

Apr 30, 2025
pulisher
Apr 30, 2025

Repligen (RGEN) Price Target Adjusted by RBC Capital Amid Market Trends | RGEN Stock News - GuruFocus

Apr 30, 2025
pulisher
Apr 30, 2025

Repligen's Q1 Earnings Beat Estimates, Revenues Surge Y/Y - Barchart.com

Apr 30, 2025
pulisher
Apr 30, 2025

Repligen Corporation (NASDAQ:RGEN) Q1 2025 Earnings Call Transcript - Insider Monkey

Apr 30, 2025

Finanzdaten der Repligen Corp-Aktie (RGEN)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$78.10
price up icon 2.94%
$189.16
price up icon 0.00%
medical_instruments_supplies COO
$72.72
price up icon 2.25%
$64.96
price down icon 0.31%
medical_instruments_supplies BAX
$31.43
price up icon 3.40%
medical_instruments_supplies WST
$223.66
price up icon 2.01%
Kapitalisierung:     |  Volumen (24h):